BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4398196)

  • 1. Isolation and structure of hypothalamic MSH release-inhibition hormone.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1971 Jun; 43(6):1376-81. PubMed ID: 4398196
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1972 Jun; 47(6):1420-5. PubMed ID: 5040241
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence.
    Matsuo H; Baba Y; Nair RM; Arimura A; Schally AV
    Biochem Biophys Res Commun; 1971 Jun; 43(6):1334-9. PubMed ID: 4936338
    [No Abstract]   [Full Text] [Related]  

  • 4. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM; Redding TW; Kastin AJ; Schally AV
    Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure of a hypothalamic peptide possessing gonadotropin-releasing activity.
    Nair RM; Schally AV
    Int J Pept Protein Res; 1972; 4(6):421-30. PubMed ID: 4569573
    [No Abstract]   [Full Text] [Related]  

  • 6. MSH-release inhibiting factors: recent studies.
    Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
    Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity studies of MSH-release-inhibiting hormone.
    Celis ME; Hase S; Walter R
    FEBS Lett; 1972 Nov; 27(2):327-30. PubMed ID: 4352026
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of growth hormone-releasing hormone(GRH) from porcine hypothalami.
    Schally AV; Sawano S; Arimura A; Barrett JF; Wakabayashi I; Bowers CY
    Endocrinology; 1969 Jun; 84(6):1493-506. PubMed ID: 4976417
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure and synthesis of the thyrotropin-releasing hormone.
    Enzmann F; Boler J; Folkers K; Bowers CY; Schally AV
    J Med Chem; 1971 Jun; 14(6):469-74. PubMed ID: 4997119
    [No Abstract]   [Full Text] [Related]  

  • 11. Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors.
    Guillemin R; Amoss M; Blackwell R; Burgus R; Grant G; Ling N; Monahan M; Rivier J; Vale W
    J Reprod Fertil Suppl; 1973 Jul; 18():23-30. PubMed ID: 4580254
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation, characterization, and amino acid sequence of melanotropins from camel pituitary glands.
    Li CH; Danho WO; Chung D; Rao AJ
    Biochemistry; 1975 Mar; 14(5):947-52. PubMed ID: 1125179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the enzymatic and chemical inactivation of hypothalamic FSH-RH.
    Schally AV; Baba Y; Redding TW; Matsuo H; Arimura A
    Neuroendocrinology; 1971; 8(6):347-58. PubMed ID: 4941967
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbon-13 NMR studies of peptide hormones and their components.
    Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
    Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).
    Burgus R; Butcher M; Amoss M; Ling N; Monahan M; Rivier J; Fellows R; Blackwell R; Vale W; Guillemin R
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):278-82. PubMed ID: 4550508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemistry of hypothalamic neurohormones. Synthesis and structure-activity relationship studies of thyrotropin-releasing hormone and luteinizing-hormone-releasing hormone.
    Sievertsson H
    Acta Pharm Suec; 1972 Feb; 9(1):19-46. PubMed ID: 4622812
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemistry of releasing hormones.
    Sandow J
    J Endocrinol; 1973 Aug; 58(2):32-3. PubMed ID: 4199267
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
    Kastin AJ; Schally AV; Viosca S
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1437-9. PubMed ID: 5316453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.